HIV-infected people exposed to tuberculosis are 30 to 50 times more likely to develop active TB.

Therapeutics

INFECTIOUS DISEASE TARGET	PRODUCT CANDIDATE	R&D PHASE
Tuberculosis	SQ109 SQ609 SQ641	Phase I Pre-clinical Pre-clinical
Systemic Fungal Infections	SQ109	Pre-clinical
Staphylococcus(including MRSA)	SQ641	Pre-clinical
Crohn’s Disease	SQ641 SQ922	Pre-clinical Pre-clinical
NonTB Mycobacteria	SQ641	Pre-clinical